Cover Story »
Thu, 05/03/2012 - 11:27

Welcome to our new website – www.the-dermatologist.com. Skin & Aging is now The Dermatologist, a name that better conveys our comprehensive coverage of the field. Please bookmark our new website so you can continue to access all new and archived content.

To read the cover story of the May issue, Office Evaluation: Gaining a Fresh Perspective, please click here.

Dermatology Topics »

Skin Cancer/Photoaging

Current and archived articles.
Search sponsored by:

Rosacea

All rosacea-related content from current research reviews to tips on treating patients dealing with this condition.

Practice Management

Content related to running a successful practice, such as solutions for common business problems, legal issues, electronic health records and coding.

Acne

All acne-related content on treatments, patient compliance issues, acne scarring and more.

Fungal Infections

Current and archived articles involving treatment and prevention of fungal infections

Psoriasis

All articles covering all types of psoriasis, including plaque, guttate, inverse, pustular and erythrodermic.

Pediatric Dermatology

Content dealing with pediatric skin issues, such as hemangiomas, MRSA, atopic dermatitis, contact dermatitis, etc.

Eczema

Current and archived articles.
Search sponsored by:

Cosmetic Dermatology

Current and archived articles.
Search sponsored by:

Laser & Light Therapies

Articles highlighting various treatments with lasers and light therapies as well as pre- and post-op care.

Online Exclusive »

Thu, 05/03/2012 - 14:17
0 Comments
203 views

Three anti-interleukin-17 biologics are in development for psoriasis that have shown promise in Phase II trials.

IL-17 is produced by neutrophils, mast cells and CD4+ and CD8+ T cells, and the two isoforms of IL-17, IL-17A and IL-17F, are expressed as homodimers and IL-17A/17F heterodimeric proteins by T cells. All three cytokines have similar functions and transduce their signals via the same IL-17 receptor complex.

The three anti-IL-17 agents in development are all monoclonal antibodies (mAbs).

Feature »

Thu, 05/03/2012 - 11:10
0 Comments
301 views

Performing a “five senses” office evaluation has the potential to significantly increase patient satisfaction and the overall success of your practice, according to a paper on service excellence in dermatology by Marks et al. The authors noted that a patient evaluates his or her care experience using all five sense - touch, taste, smell, hearing and vision - and suggest that doctors and office staff conduct a “five senses” clinic evaluation to ensure that the care environment is optimal for patients.

Feature »

Thu, 05/03/2012 - 10:47
0 Comments
341 views

Current reports estimate that anywhere between 15% and 40% of dermatology patients suffer from comorbid psychological issues that are directly attributed to the skin condition, but there are a number of simple, powerful steps that dermatologists can take to help patients manage — and overcome — these issues. This extra step may be as simple as taking a few extra minutes to talk with patients about the emotional impact of their skin condition.